Lataa...
Pharmaceutical companies’ views on a health technology assessment (HTA) entity in Saudi Arabia
Saudi Arabia is undergoing a massive healthcare transformation to fulfill its new, national “Vision 2030.” To align with this objective, Saudi Arabia is establishing a new, independent and evidence-based health technology assessment (HTA) entity to help it maximize health gains through efficient use...
Tallennettuna:
| Julkaisussa: | Saudi Pharm J |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7292859/ https://ncbi.nlm.nih.gov/pubmed/32550796 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsps.2020.04.006 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|